NanoCarrier (ナノキャリア株式会社) is a company engaged in the research and development of pharmaceuticals using micellar nanoparticle technology. Its main products include NC-6004, a Cisplatin-based formulation for the treatment of pancreatic, head and neck, non-small cell lung, bladder, and biliary tract cancers, and NC-4016, a DachPt micelle formulation for solid cancers.